Who owns Provectus Biopharmaceuticals I?

Tip: Access positions for across all investors

Analyze quarterly positions in Provectus Biopharmaceuticals I with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Provectus Biopharmaceuticals I stock

Who bought or sold Provectus Biopharmaceuticals I this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Home Federal Bank Of Tennessee 100k $9.6k 0% Dec 2023
 View chart
Lee, Danner & Bass 50k $5.0k 0% Dec 2023
 View chart
Atlas Wealth 27k $2.2k 0% Dec 2023
 View chart
LBMC Investment Advisors 22k $2.1k 0% Dec 2023
 View chart
Academy Capital Management 20k $1.7k 0% Sep 2023
 View chart
Financial Symmetry 10k $978.336000 100% Dec 2023
 View chart
Huntington National Bank 1.00 $0 0% Dec 2023
 View chart